Thorough examination of the different PON1 -omics layers enables us to postulate about the involvement of complex (epi)genetic mechanisms and gene expression modulation as an explanation for the observed PON1 association with NAFLD severity. This evidence concerns the gene PON1 and metabolic dysfunction-associated steatotic liver disease.